Costa, L., Oriol, A., Dytfeld, D., Manier, S., Voorhees, P., Lin, Y., Htut, M., Roeloffzen, W., Ho, P. J., Shah, U., Zhao, M., Li, Q., Balogh, A., Li, K., Slaughter, A., Benachour, N., Lonardi, C., Ghosh, A., Sun, H., Lendvai, N., Lengil, T., Patel, N., Koneru, M., Florendo, E., Costa, O., Mahajan, V., Rodriguez-Otero, P., Strouse, C., Stewart, K., Sidana, S. (2025). Long-term progression-free survival benefit with ciltacabtagene autoleucel in standard-risk relapsed / refractory multiple myeloma. Blood. https://doi.org/10.1182/blood-2025-94